Interesting Study.....
The Market Ticker - Cancelled - What 'They' Don't Want Published
Login or register to improve your experience
Main Navigation
Sarah's Resources You Should See
Sarah's Blog
Full-Text Search & Archives
Leverage, the book
Legal Disclaimer

The content on this site is provided without any warranty, express or implied. All opinions expressed on this site are those of the author and may contain errors or omissions. For investment, legal or other professional advice specific to your situation contact a licensed professional in your jurisdiction.

NO MATERIAL HERE CONSTITUTES "INVESTMENT ADVICE" NOR IS IT A RECOMMENDATION TO BUY OR SELL ANY FINANCIAL INSTRUMENT, INCLUDING BUT NOT LIMITED TO STOCKS, OPTIONS, BONDS OR FUTURES.

Actions you undertake as a consequence of any analysis, opinion or advertisement on this site are your sole responsibility; author(s) may have positions in any firm or security discussed here, and have no duty to disclose same.

The Market Ticker content may be sent unmodified to lawmakers via print or electronic means or excerpted online for non-commercial purposes provided full attribution is given and the original article source is linked to. Please contact Karl Denninger for reprint permission in other media, to republish full articles, or for any commercial use (which includes any site where advertising is displayed.)

Submissions or tips on matters of economic or political interest may be sent "over the transom" to The Editor at any time. To be considered for publication your submission must be complete (NOT a "pitch"), include full and correct contact information and be related to an economic or political matter of the day. Pitch emails missing the above will be silently deleted. All submissions become the property of The Market Ticker.

Considering sending spam? Read this first.

2025-03-10 07:00 by Karl Denninger
in Personal Health , 78 references Ignore this thread
Interesting Study.....
[Comments enabled]

Its one study but this, in immune-competent people without material hemorrhage risk looks like something worth doing as an adjunct to cancer treatment as it has quite-low risk provided the other things you're doing don't interfere with clotting.

In short it appears that ordinary aspirin, in modest doses, suppresses metastasis of existing cancer.  The hazard ratio they found is rather impressive -- it is not a 100% response by any means, but since spread of a primary tumor is an "aw ****" sort of thing while focused further investigation certainly is in order this is an extremely inexpensive and, provided there are no hemorrhagic concerns, looks like a good "bang for the buck on risk" addition with nearly zero cost.

Note that inhibition of COX-2 did not result in benefit; thus acetaminophen (Tylenol) would not be expected to work as that blocks COX-2 and it is unknown if ibuprofen will help (it blocks both non-selectively.)

Aspirin can be extremely dangerous if you have a condition, or are using other drugs, that potentiate bleeding -- including the possibility of causing hemorrhagic strokes, which are usually fatal, so it is very important, especially if you're using other medications (and you probably will be if you have cancer!) to know if there is an interaction risk or you have a hemorrhage risk already, and in addition if your immune system is compromised whether it would be beneficial is questionable.  Thus this isn't really a "do it yourself" sort of thing, but it is a very interesting study with an unexpected finding.

Oh, and its not the first one either -- so why isn't this part of the standard recommendations?

You know damn well what the answer is -- at 2 cents a pill nobody can make any money on it.

Go to responses (registration required to post)
 

 
No Comments Yet.....
Login Register Top Blog Top Blog Topics FAQ
Page 1 of 25  First123456789Last
Login Register Top Blog Top Blog Topics FAQ
Page 1 of 25  First123456789Last